Efficacy News and Research

RSS

Cyanotriazole compounds can selectively and rapidly kill trypanosome parasites, study shows

Cyanotriazole compounds are fast-acting topoisomerase II poisons that can selectively and rapidly kill trypanosome parasites that cause Chagas disease and African sleeping sickness, according to a new study.

29 Jun 2023

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Multiple members of The Obesity Society (TOS) unveiled new research about several anti-obesity medications in development at this year's annual meeting of the American Diabetes Association (ADA) held June 23–26.

29 Jun 2023

Water fasting's metabolic benefits may be short-lived

Water fasts - where people consume nothing but water for several days - might help you lose weight, but it's unclear how long you'll keep it off, according to research from the University of Illinois Chicago.

29 Jun 2023

MDXX drugs: A promising new therapy for autism spectrum disorder

A new review in the peer-reviewed journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogs, or MDXX drugs, and how they may help treat autism spectrum disorder (ASD).

29 Jun 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

29 Jun 2023

New drug effective as a treatment against ulcerative colitis, clinical trial shows

A new drug, investigated by Amsterdam UMC together with colleagues around the world, is effective as a treatment against ulcerative colitis.

28 Jun 2023

New study reveals alarming cognitive impairments in long COVID patients

Persistent COVID-19 symptoms can lead to cognitive deficits in recovered patients. This systematic review highlights the need for further research and interventions to address long-term cognitive impairments.

28 Jun 2023

Experimental antibody treatment shows promise for preventing bone marrow transplant complication

An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children's Cancer and Blood Disorders Center and published today in Science Translational Medicine.

28 Jun 2023

Uncertain language in e-cigarette warning labels can confuse people, study finds

When it comes to e-cigarette warning labels, respondents in focus groups organized by Cornell researchers were clear: Give it to me straight.

28 Jun 2023

Pyroptosis: A potential therapeutic target for lung cancer

Lung cancer, one of the most aggressive forms of cancer, continues to be a leading cause of death worldwide. Although several new therapies have been developed for this disease, it has a poor prognosis in its advanced stages.

28 Jun 2023

Researchers develop light-controlled drug delivery system using liposomes

Artificial lipid bilayer vesicle liposomes, also called proteoliposomes, are specialized systems capable of incorporating various molecules, such as chemicals and drugs.

28 Jun 2023

SARS-CoV-2 mRNA vaccination induces an immune response in the nasal mucosa, study finds

Respiratory viruses are known for their ability to enter the body through the eyes, nose, or mouth. Our bodies know that, too.

28 Jun 2023

Chatbot interventions effective in improving physical activity, diet, and sleep

Research finds that chatbot interventions are effective in improving physical activity, diet, and sleep. The study highlights the efficacy of chatbots across different populations and age groups, emphasizing their potential for personalized healthcare delivery.

27 Jun 2023

New method could revolutionize the delivery of antioxidants to stem cells

As we age, our bodies change and degenerate over time in a process called senescence. Stem cells, which have the unique ability to change into other cell types, also experience senescence, which presents an issue when trying to maintain cell cultures for therapeutic use.

27 Jun 2023

Metabolic surgery provides better results, lesser regression than standard diabetes management

Metabolic or bariatric surgery results in superior glycemic control, less medication usage and high rates of remission of Type 2 diabetes than medical or lifestyle intervention in patients with class 1 obesity, as described in a recently published report by researchers of Pennington Biomedical Research Center and others.

27 Jun 2023

Research shows the efficacy of methionine restriction to reverse old-age-induced obesity

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 11, entitled, "Old-age-induced obesity reversed by a methionine-deficient diet or oral administration of recombinant methioninase-producing Escherichia coli in C57BL/6 mice."

27 Jun 2023

New studies show bariatric surgery can improve health for patients with Class 1 obesity

Patient eligibility for bariatric surgery, also called weight-loss or metabolic surgery, has expanded over the last decade and its safety and effectiveness even further established in clinical studies and professional guidelines, but relatively few patients with a body mass index (BMI) below 35 actually get the surgery in any given year, according to new studies presented here at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2023 Annual Scientific Meeting.

27 Jun 2023

Is there an association between muscle-building supplements and DNA damage in resistance training practitioners?

A recent study investigated whether muscle-building supplements are associated with DNA damage in individuals practicing resistance training.

27 Jun 2023

Efficacy News and Research

Cyanotriazole compounds can selectively and rapidly kill trypanosome parasites, study shows

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Water fasting's metabolic benefits may be short-lived

MDXX drugs: A promising new therapy for autism spectrum disorder

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

New drug effective as a treatment against ulcerative colitis, clinical trial shows

New study reveals alarming cognitive impairments in long COVID patients

Experimental antibody treatment shows promise for preventing bone marrow transplant complication

Uncertain language in e-cigarette warning labels can confuse people, study finds

Pyroptosis: A potential therapeutic target for lung cancer

Researchers develop light-controlled drug delivery system using liposomes

SARS-CoV-2 mRNA vaccination induces an immune response in the nasal mucosa, study finds

Chatbot interventions effective in improving physical activity, diet, and sleep

New method could revolutionize the delivery of antioxidants to stem cells

Metabolic surgery provides better results, lesser regression than standard diabetes management

Research shows the efficacy of methionine restriction to reverse old-age-induced obesity

New studies show bariatric surgery can improve health for patients with Class 1 obesity

Is there an association between muscle-building supplements and DNA damage in resistance training practitioners?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News